In addition to NAION, there is also evidence to suggest GLP-1 drugs can worsen diabetic eye disease, also known as diabetic retinopathy
doi: 10.1016/j.molmet.2019.07.008 Summary Keywords metabolic dysfunction-associated fatty liver disease (MASLD), non-alcoholic fatty liver disease (NAFLD), type 2 diabetes mellitus (T2DM), insulin resistance (IR), hepatic steatosis, lipotoxicity, inflammation, adipokines Citation Mohiuddin MS, Neha NT, Mahir JUK, Shakib FAF, Alam MA, Wahiduzzaman M, Barua R, Shimu SJ, Rahman M, Hossain MR, Shariare MH, Mohib MM and Uddin MB (2025) Metabolic dysfunction associated fatty liver disease and type 2 diabetes: pathophysiological links, epidemiological trends, and clinical implications
Also, weight loss was greater: 6.2 kg for Ozempic vs
What kind of taurine is present in energy drinks
Endocrinology 145 , 40374047 (2004)
A high-quality multivitamin daily insurance policy for micronutrient gaps Why supplements matter on GLP-1 medications GLP-1 receptor agonists work in part by slowing gastric emptying and suppressing appetite in the brain